3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
33
Thoracic
7
Genitourinary
5
Sarcoma
3
Gastrointestinal
3
Lymphoid
2
Gynecologic
2
Breast
2
Plasma cell
1
Head & Neck
1
CNS
1
Conditions
Breast Neoplasms
118
Lung Neoplasms
9
Neoplasms
8
Triple Negative Breast Neoplasms
7
Ovarian Neoplasms
7
Neoplastic Cells, Circulating
6
Neoplasm Metastasis
5
Prostatic Neoplasms
4
Recurrence
3
Pancreatic Neoplasms
3
Hodgkin Disease
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Obesity
2
Melanoma
2
Lymphoma
2
Liver Neoplasms
2
Leukemia
2
Genetic Diseases, Inborn
2
Fibrosis
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Breast Diseases
2
Vulvar Neoplasms
1
Interventions
pembrolizumab
44
Cyclophosphamide
21
Nivolumab
18
fludarabine
10
durvalumab
8
Paclitaxel
8
Magnetic Resonance Spectroscopy
8
Interleukin-2
8
Docetaxel
8
aldesleukin
7
Radiosurgery
7
Ipilimumab
7
spartalizumab
6
poly ICLC
6
fludarabine phosphate
6
atezolizumab
6
Specimen Handling
6
Radiotherapy
6
Carboplatin
6
cemiplimab
5
Drug Therapy
5
Cisplatin
5
Biopsy
5
Temozolomide
4
Immune Checkpoint Inhibitors
4
tremelimumab
3
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
3
pazopanib
3
avelumab
3
Trastuzumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Melanoma
×
Blood Specimen Collection
×
Breast
×
Clear all
NCT02831634
2025-09-08
NeoEpitope
Institut Curie
Phase NA
Completed
25 enrolled
NCT03787056
2021-07-16
ONCOPRO
Hospices Civils de Lyon
Phase NA
Recruiting
410 enrolled